As of 30 Sep 2025, 20 institutional investors reported holding 2,172,474 shares of Alpha Tau Medical Ltd. - *W EXP 99/99/999 (DRTSW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 2,172,474 | $8,788,757 | -$11,007 | $0.34 | 20 |
| 2025 Q2 | 2,194,579 | $8,739,947 | +$8,263,501 | $0.23 | 20 |
| 2025 Q1 | 2,039,358 | $473,485 | -$51,174 | $0.24 | 22 |
| 2024 Q4 | 3,244,292 | $681,370 | -$23,762 | $0.21 | 25 |
| 2024 Q3 | 3,229,063 | $612,570 | -$51,757 | $0.19 | 29 |
| 2024 Q2 | 3,763,842 | $807,147 | -$5,215 | $0.21 | 28 |
| 2024 Q1 | 3,783,647 | $924,844 | +$23,419 | $0.25 | 30 |
| 2023 Q4 | 50,445 | $9,716 | $0.19 | 1 | |
| 2023 Q3 | 3,792,248 | $989,026 | +$8,316 | $0.26 | 29 |
| 2023 Q2 | 75,009 | $29,636 | -$51,513 | $0.40 | 5 |
| 2023 Q1 | 3,173,737 | $973,471 | -$25,368 | $0.29 | 33 |
| 2022 Q4 | 3,308,859 | $835,699 | -$274,025 | $0.25 | 31 |
| 2022 Q3 | 4,248,834 | $1,884,000 | +$413,095 | $0.44 | 33 |
| 2022 Q2 | 3,483,520 | $1,699,878 | -$289,292 | $0.48 | 31 |
| 2022 Q1 | 4,200,779 | $2,561,000 | +$2,552,999 | $0.61 | 37 |